EDGAR Filing Documents for 0001104659-17-061030

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001104659-17-061030

Filing Date

2017-10-05

Accepted

2017-10-05 11:10:56

Documents

Period of Report

2017-10-05

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	a17-22756_16k.htm	6-K	27307
2	EX-1.1	a17-22756_1ex1d1.htm	EX-1.1	322975
3	EX-5.1	a17-22756_1ex5d1.htm	EX-5.1	66808
4	EX-99.1	a17-22756_1ex99d1.htm	EX-99.1	12174
5	EX-99.2	a17-22756_1ex99d2.htm	EX-99.2	12454
	Complete submission text file	0001104659-17-061030.txt		442778

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053

Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200

Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 6-K | Act: 34 | File No.: 001-37569 | Film No.: 171123608
SIC: 2834 Pharmaceutical Preparations